Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

The following tables present certain information regarding our stockholders’ equity (deficit) as of March 31, 2023 and 2022:


	Three Months Ended March 31, 2023
	Common Stock		Additional Paid in Capital		Retained Earnings		Treasury Stock		Accumulated Other Comprehensive Loss		Noncontrolling Interest		Total
January 1, 2023	$	1	$	1,370	$	517	$	(580)	$	(318)	$	171	$	1,161
Settlement of liability awards	—		25		—		—		—		—		25
Vesting of RSUs, net of tax withholdings and other	—		(14)		—		—		—		—		(14)
Purchase of treasury stock	—		—		—		(28)		—		—		(28)
Purchase of SciPlay’s Class A common stock	—		(8)		—		—		—		—		(8)
Stock-based compensation	—		15		—		—		—		—		15
Net income	—		—		22		—		—		5		27
Other comprehensive income	—		—		—		—		6		—		6
March 31, 2023	$	1	$	1,388	$	539	$	(608)	$	(312)	$	176	$	1,184


	Three Months Ended March 31, 2022
	Common Stock		Additional Paid in Capital		Accumulated Loss		Treasury Stock		Accumulated Other Comprehensive Loss		Noncontrolling Interest		Total
January 1, 2022	$	1	$	1,337	$	(3,158)	$	(175)	$	(261)	$	150	$	(2,106)
Settlement of liability awards	—		43		—		—		—		—		43
Vesting of RSUs, net of tax withholdings and other	—		(31)		—		—		—		—		(31)
Purchase of treasury stock	—		—		—		(51)		—		—		(51)
Stock-based compensation	—		17		—		—		—		—		17
Net income	—		—		26		—		—		2		28
Other comprehensive loss	—		—		—		—		(37)		—		(37)

March 31, 2022	$	1	$	1,366	$	(3,132)	$	(226)	$	(298)	$	152	$	(2,137)

Schedule of Stock-based Compensation Expense Recognized

The following reflects total stock-based compensation expense recognized under all programs:


	Three Months Ended March 31,
	2023		2022

Related to L&W RSUs	$	19	$	12
Related to SciPlay RSUs	7		3
Total(1)	$	26	$	15

(1) Includes $11 million and $4 million of stock-based compensation classified as liability awards as of March 31, 2023 and 2022, respectively.

Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity

A summary of the changes in RSUs outstanding under our equity-based compensation plans during the three months ended March 31, 2023 is presented below:


	Number of Restricted Stock Units	Weighted Average Grant Date Fair Value
Unvested RSUs as of December 31, 2022	1.7	$	46.66
Granted	1.0	$	56.93
Vested	(0.8)	$	45.36
Cancelled	—	$	45.60
Unvested RSUs as of March 31, 2023	1.9	$	52.72